Candida albicans biofilms are intrinsically resistant to antimicrobial agents. Previous work demonstrated that the antifungal activity of fluconazole against C. albicans biofilms is notably enhanced by doxycycline. In order to explore the synergistic mechanism of fluconazole and doxycycline, we investigated the changes of efflux pump gene expression, intracellular calcium concentration and cell cycle distribution after drug intervention in this study. The expression levels of CDR1, CDR2 and MDR1 were determined by real-time PCR, and the results showed that fluconazole alone could stimulate the high expression of CDR1, CDR2 and MDR1, and the combination of doxycycline and fluconazole downregulated the gene overexpression induced by fluconazole. Intracellular calcium concentration was determined using Fluo-3/AM by observing the fluorescence with flow cytometry. A calcium fluctuation, which started 4 h and peaked 8 h after the treatment with fluconazole, was observed. The combined drugs also initiated a calcium fluctuation after 4 h treatment and showed a peak at 16 h, and the peak was higher than that stimulated by fluconazole alone. The cell cycle was measured using flow cytometry. Fluconazole alone and the combined drugs both induced a reduction in the percentages of S-phase cells and an elevation in the percentages of cells in the G 2 /M phase. The results of this research showed that the synergism of fluconazole and doxycycline against C. albicans biofilms is associated with blockade of the efflux pump genes CDR1, CDR2 and MDR1, and stimulation of high intracellular calcium concentration. The findings of this study are of great significance in the search for new antifungal mechanisms.
INTRODUCTION
Candida albicans is able to adhere to surfaces of the medical material used for intravascular catheters, endotracheal tubes, artificial heart valves, joint prostheses, etc., resulting in the generation of biofilms. C. albicans biofilms are resistant to the majority of antimycotics (Hawser & Douglas, 1995) and are therefore difficult to treat. Recently, synergism against C. albicans biofilms has been reported when high-dose doxycycline was combined with fluconazole, amphotericin B and caspofungin (Miceli et al., 2009 ). In our previous research, we demonstrated that the antifungal effect of fluconazole could be sensitized by doxycycline at a concentration of 1-64 mg l 21 against C. albicans biofilms (Gao et al., 2013) . However, as for research on the mechanism, Fiori & Van Dijck (2012) reported that iron depletion may account for the synergism of fluconazole and doxycycline against planktonic cells, and no other mechanism has been reported. Thus, the precise synergistic mechanism of fluconazole and doxycycline against C. albicans biofilms remains unknown and needs exploration.
The mechanisms responsible for drug resistance associated with C. albicans biofilms are complex. Recent research revealed that drug efflux pump genes were overexpressed during the course of C. albicans biofilm formation and development, which indicated that the efflux pump contributes to biofilm resistance (Ramage et al., 2002; Watamoto et al., 2011) . The drug efflux in C. albicans is mostly related to the ATP-binding cassette (ABC) transporters and the major facilitator superfamily transporters. The ABC transporters are encoded by Candida drug resistance genes CDR1 and CDR2, and the major facilitator superfamily transporters are encoded by the multidrug resistance gene MDR1 (Albertson et al., 1996; Sanglard et al., 1997) . Research has shown that azole resistance associated with overexpression of efflux pumps could be reverted by some modulators, such as ibuprofen, verapamil and sex hormones (Ford & Hait, 1990; Pina-Vaz et al., 2005) , which allows reversion of resistance through blocking the efflux pumps. Thus, here we investigated whether the synergism induced by fluconazole and doxycycline was associated with the blockade of efflux pump genes.
C. albicans has evolved a complex network of mechanisms in response to drug resistance and one of them is calcium homeostasis. In C. albicans, calcium homeostasis is essential in developmental and stress signalling pathways (Bader et al., 2006) . It has been reported that calcium-associated pathways are related to key pathogenic steps in fungi, including C. albicans (Reedy et al., 2010) . Research revealed that the antifungal effects of some agents are associated with calcium homeostasis disturbance. In our previous studies, the combination of fluconazole and minocycline caused a significant increase of intracellular calcium (Shi et al., 2010) . In addition, a significant inhibition of fungal growth was found when calcium channel blockers (benidipine and nifedipine) were combined with fluconazole and doxycycline (Gao et al., 2013) , which suggested that synergism may be related to the change of cytoplasmic calcium. In order to confirm this hypothesis, the cytosol calcium concentration was determined when C. albicans sessile cells were treated with fluconazole and doxycycline in this study.
Recently, with the emergence of widespread resistance to antifungal drugs, several therapeutic strategies have been explored, including targeting the cell cycle. Much of the current study has led to our understanding of the antifungal mechanism associated with cell cycle arrest. For example, amphotericin B has already been demonstrated to induce apoptosis through arresting the cell cycle (Phillips et al., 2003) . The antifungal effects of amentoflavone, terpenoids and plagiochin E were also reported to be associated with cell cycle arrest (Jung et al., 2007; Wu et al., 2010; Zore et al., 2011) . As a consequence, cell cycle arrest was considered as one of the antifungal pathways.
Therefore, in this study we investigated the expression of the resistance genes CDR1, CDR2 and MDR1, the intracellular calcium concentration, and the distribution of the cell cycle in C. albicans biofilms after exposure to the doxycycline and fluconazole drug combination. Any discovery could be of great significance in finding new antifungal mechanisms.
METHODS
Strains and media. (Gao et al., 2013) . The isolates were maintained in YPD medium (1 % yeast extract, 2 % peptone, 2 % glucose) (Ding Guo Biological) at 270 uC. They were propagated and subcultured on YPD solid medium at least twice to ensure purity and viability before each experiment.
Antimicrobial agents. Fluconazole was provided by Cheng Chuang Pharmaceutical and doxycycline was purchased from An Bei Ka Pharmaceutical. They were dissolved in distilled water and DMSO, respectively. The concentration of stock solution of fluconazole was 2.56 g l 21 and the concentration of stock solution of doxycycline was 6.4 g l
21
. Stock solutions were kept at 270 uC until use.
Preparation of C. albicans biofilms and drug interventions. C. albicans biofilms were formed on polystyrene 12-well plates. Cells were first suspended in RPMI-1640 (Gibco-BRL) supplemented with glucose to a final concentration of 2 % and buffered with 0.165 M MOPS (Ding Guo Biological) to pH 7.0, standardized to a cell density of 1.0610 5 cells ml
. Then, 1 ml cell suspensions were pipetted into microtitre plates and incubated overnight at 37 uC. In our previous works, we used C. albicans biofilms that formed over 4, 8, 12 , and 24 h, and we discovered that the overnight biofilm was mature enough to evaluate the drug effect (Gao et al., 2013) . Each well of the plates was washed with PBS (pH 7.2-7.4; Solarbio Science & Technology) to remove planktonic cells and then the biofilm was obtained. C. albicans biofilms were incubated with drugs (4 mg l 21 fluconazole and 8 mg l 21 doxycycline) for 24 h. The cells were then washed with PBS and processed for research on the synergistic mechanism.
RNA extraction, cDNA synthesis and quantitative real-time (RT)-PCR. Total cellular RNA was extracted using the hot phenol method (Schmitt et al., 1990) . Briefly, 12 ml AE buffer (50 mM sodium acetate pH 5.2, 10 mM EDTA) was used to suspend the frozen cells at room temperature, then 800 ml 25 % SDS and 12 ml acid phenol (Fisher Science) were added. The cells were incubated with vortexing each minute for 10 min at 65 uC and cooled on ice for 5 min; then they were centrifuged for 15 min at 11 952 g. Supernatants were transferred to a new tube, mixed with 15 ml chloroform and centrifuged at 200 g for 10 min. The aqueous layer was transferred to a new tube containing 1 vol. 2-propanol and 0.1 vol. 2 M sodium acetate (pH 5.0), and the mixture was centrifuged at 17 211 g for 35 min at 4 uC. The precipitation was resuspended in 10 ml 70 % ethanol and the mixture was centrifuged at 17 211 g for 20 min at 4 uC. The RNA pellet was resuspended in diethylpyrocarbonate-treated water. RNA concentrations were quantified spectrophotometrically and the samples were stored at 280 uC until use.
The cDNA was synthesized using the First-Stand cDNA Synthesis SuperMix (TransGen Biotech) according to the manufacturer's instructions. All of the reagents, as well as 2 mg cellular RNA, were added to a final volume of 20 ml, and then the samples were incubated at 42 uC for 30 min and 85 uC for 5 min. The synthesized cDNA samples were stored at 220 uC until use. The PCR primers used in this assay were designed and synthesized by Sangon Biological Engineering Technology and Services (Shanghai, China) and the specificity of each primer was checked by comparing its sequence with the C. albicans database by BLAST at the National Center for Biotechnology Information. The sequences of the primers are listed in Table 1 . The RT-PCR was carried out with an ABI ViiA 7 (Applied Biosystems) sequence detection system using SYBR Green I (Cwbiotech) in duplicate for three separate experiments. An aliquot of 25 ml PCR mix was used for each gene and the cycling conditions were 95 uC for 10 min, followed by 40 cycles of 95 uC for 15 s and 60 uC for 1 min. Fluorescence intensities were quantified by using StepOne software (Applied Biosystems). The expression of the ACT housekeeping gene was used as a control and the relative quantities of the target genes were analysed using the comparative DDC t method (Pfaffl, 2001 ). The comparison of data among four groups (control, fluconazole-alone, doxycycline-alone and fluconazole combined with doxycycline) was determined by one-way ANOVA, followed by Dunnett's test using SPSS Statistics software and significance was defined as P,0.01.
Intracellular calcium detection. The calcium-sensitive indicator Fluo-3/AM (Biotium) was used to evaluate the intracellular calcium (Wang et al., 2011) ; it is readily hydrolysed to Fluo-3 free acid and becomes activated in cytoplasm when passively loaded into cells. Fluo-3/AM was dissolved in 20 % Pluronic F-127 (Biotium) DMSO solvent at a concentration of 1 mg ml 21 . Cells were loaded with Fluo-3/AM at a final concentration of 5 mM for 30 min at 37 uC. The cells were then washed three times with D-Hanks buffer (KCl 0.4 g, KH 2 PO 4 0.06 g, NaCl 8.0 g, NaHCO 3 0.35 g, Na 2 HPO 4 .7H 2 O 0.09 g dissolved in 1 l distilled water). Calcium levels were determined by flow cytometry using a FACScan flow cytometer (Becton Dickinson) with excitation at 488 nm and emission at 525 nm.
Cell cycle analysis. DNA content was quantified with the DNAspecific fluorescent dye propidium iodide (PI). The C. albicans strains were first washed twice with PBS and then fixed with cold 70 % ethanol (in PBS) at 4 uC overnight. The cells were centrifuged at 1000 g and washed twice with PBS. RNase A (final concentration 0.2 mg ml 21 ) was added to the cells and the mixture was allowed to react at 50 uC for 2 h. After the reaction, PI (final concentration 0.05 mg ml 21 ) was added and the samples were stained for 30 min in the dark. DNA content was determined by a FACScan flow cytometer (Becton Dickinson) with excitation at 488 nm and emission at 630 nm. The data were analysed using WINMDI 2.9 software (Joseph Trotter, The Scripps Institute, La Jolla, CA, USA).
RESULTS

Expression of genes encoding efflux pumps in response to combined drugs
The gene expression results for CA10 are shown in Fig. 1 . Fluconazole significantly increased CDR1 expression compared with the control group by 389 % (P,0.01), and the combination of fluconazole and doxycycline downregulated the CDR1 high expression significantly compared with fluconazole challenge alone by 65 % (P,0.01). Expression of CDR1 was downregulated on doxycycline challenge compared with the control group by 54 % (P,0.01). CDR2 expression was depressed by doxycycline and increased by fluconazole challenge (P,0.01), 59 and 57 %, respectively. The drug combination downregulated CDR2 expression to a significant extent compared with fluconazole alone by 81 % (P,0.01). MDR1 overexpression was observed with the intervention of fluconazole alone and the combination treatment dampened this transcriptional response significantly by 47 % (P,0.01). The efflux pump gene expression of the fluconazole-susceptible strain CA1 was also tested in this study. For CA1 biofilms, fluconazole alone could stimulate the overexpression of CDR1, CDR2 and MDR1, and the combination of doxycycline and fluconazole downregulated this gene overexpression. Therefore, no significantly different results were observed compared with CA10 (data not shown).
Intracellular Ca 2+ levels change upon drug combination
The intracellular Ca 2+ level following treatment with the doxycycline and fluconazole drug combination was determined by the fluorescent calcium indicator Fluo-3/ AM, and the results for CA10 are shown in Fig. 2 . In the control and doxycycline-alone groups, the intracellular levels of Ca 2+ were rather low and changed very little over time. Treatment of the cells with fluconazole alone resulted in an apparent calcium fluctuation, which started 4 h and peaked 8 h after the treatment. More complex changes were observed when the cells were challenged with the doxycycline and fluconazole drug combination. In the first 4 h, the intracellular level of Ca 2+ was as low as the control group, and then an obvious increase in fluorescence was observed and lasted for 4 h. The increase became slower after 8 h challenge and showed a peak at 16 h. Moreover, we observed that this peak was higher than that stimulated with fluconazole alone (P,0.01). 
Effects of combined drugs on the cell cycle
The cell cycle was analysed to explore how the combined drugs inhibited cell proliferation and the results for CA10 are shown in Fig. 3 . In the control group, the percentages of cells in different phases were all evenly distributed (between 30 and 35 %). The result for treatment with doxycycline alone was similar to the control group. An obvious difference in the cell cycle distribution was observed when the cells were exposed to fluconazole alone. The results show a reduction in the percentage of S-phase cells (from 34.6 to 6.0 %) and an elevation in the percentage of cells in the G 2 /M phase (from 32.7 to 71.8 %), indicating that fluconazole induced cell cycle arrest within the G 2 /M phase in C. albicans biofilms. For the combined group, the cell percentages of S phase and G 2 /M phase were similar to those of the fluconazole-alone group (6.4 and 66.1 %, respectively). However, the combination of doxycycline and fluconazole resulted in cell arrest in the G 2 /M phase to a weaker extent compared with the fluconazole-alone group.
DISCUSSION
Drug combination has recently been used to improve the effect of fluconazole therapy for C. albicans biofilms (Bink et al., 2011) . In previous studies, we found that fluconazole susceptibility against C. albicans biofilms could be increased by doxycycline (Gao et al., 2013) . In order to understand the synergistic effect of fluconazole and doxycycline, the possible mechanisms were analysed in this study.
In our previous study, the synergistic effect of fluconazole and doxycycline was found to change with the sensitivities of the C. albicans isolates tested (six azole-resistant strains, one azole-susceptible dose-dependent strain, and three azoleresistant strains), and a stronger effect was observed on resistant strains compared with susceptible strains (Gao et al., 2013) . The efflux pump was considered as one of the common fungal resistance mechanisms (Ramage et al., 2002) , and thus the mRNA levels for CDR1, CDR2 and MDR1 were analysed in this study. We found that the expression levels of CDR1 and CDR2 were downregulated slightly when biofilms were exposed to doxycycline alone. Fluconazole alone can obviously upregulate the expression levels of CDR1 and CDR2, and thus gene overexpression was downregulated by the fluconazole and doxycycline drug combination. These results indicated that doxycycline alone has an influence on CDR1 and CDR2 expression, and the blockade of the two efflux pumps could be achieved when doxycycline is combined with fluconazole. In addition, MDR1 was upregulated by fluconazole alone and the combination treatment dampened this overexpression significantly. No significant variation of MDR1 expression was induced by doxycycline alone. These results demonstrated that MDR1 overexpression could be induced by fluconazole alone and this overexpression could be reversed by fluconazole combined with doxycycline. A study of the synergistic mechanism of tetracycline and amphotericin B in C. albicans demonstrated that the tetracycline effect on amphotericin B was independent of efflux pump gene expression, including CDR1, CDR2 and MDR1 (Oliver et al., 2008) . However, the results of this study showed that the combination of fluconazole and doxycycline induced the inhibition of expression of efflux pump genes CDR1, CDR2 and MDR1. The possible reason for the discrepancy is that different antifungal agents (amphotericin B and fluconazole, respectively) were combined and different states of the isolates (planktonic cells and biofilms) were tested.
In fungi, calcium is a basal nutrient for the regulation of several processes as well as a vital second messenger in cell growth (Bader et al., 2006) . Evidence has shown that cytosolic calcium entry in yeast cells is critical for survival under stresses (Cruz et al., 2002) . It has been demonstrated that calcium influx is responsible for the fungicidal activity of amiodarone (Gupta et al., 2003) . Furthermore, in previous research, we found that the synergistic effect of fluconazole and doxycycline could be enhanced by calcium channel blockers (benidipine and nifedipine) (Gao et al., 2013) , which suggested that the combined drug-mediated growth inhibition seems to be related to calcium disturbance. In this study, intracellular calcium concentrations were detected to determine whether intercellular calcium changes in C. albicans biofilms could be induced by the combination of fluconazole and doxycycline. We observed that there was an increase of intracellular calcium levels after the 4 h intervention of fluconazole and it reached a peak at 8 h. An intracellular calcium burst was also induced by the combined drugs, which was more durable and stronger than that induced by fluconazole alone. Excessive intracellular calcium is known to be toxic (McConkey & Orrenius, 1997) , therefore we speculate that one of the synergistic mechanisms is the high intracellular calcium level stimulated by fluconazole and doxycycline. A rise in cytoplasmic calcium has been shown to be responsible for Saccharomyces cerevisiae apoptosis (Pozniakovsky et al., 2005) . Studies have suggested that H 2 O 2 -induced C. albicans biofilm apoptosis is associated with calcium ions and the downstream calcineurin/Crz1p/CaMCA1 pathway (Lu et al., 2011) . However, whether the combined druginduced high intracellular calcium level has a relationship with apoptosis needs further study.
The cell cycle is an evolutionarily conserved process in all eukaryotic cells, and it is used to control growth and division (Jacks & Weinberg, 1996) . Cell cycle arrest could be induced by many agents in yeast, including amphotericin B (Phillips et al., 2003) , amiodarone (Zhang & Rao, 2007) , paclitaxel (Foland et al., 2005) , etoposide (Sabourin et al., 2003) and camptothecin (Kauh & Bjornsti, 1995) . In order to explore whether the drug combination of fluconazole and doxycycline induced the cell cycle arrest of C. albicans biofilms, the effect of the combined drugs on cell proliferation was determined. The results showed that increases in the percentage of cells in G 2 /M phase and decreases in the percentage of cells in S phase were promoted by fluconazole alone. The drug combination of fluconazole and doxycycline caused arrest in the G 2 /M phase to a weaker extent compared with the fluconazolealone group. Those results suggested that fluconazole alone could cause cell cycle arrest and that the synergism was independent of cell cycle arrest.
This study discovered the potential synergistic mechanisms of fluconazole and doxycycline against C. albicans biofilms. The results showed that the synergism of fluconazole and doxycycline against C. albicans biofilms is associated with the blockade of efflux pump genes CDR1, CDR2 and MDR1. Furthermore, we discovered that stimulation of a high intracellular calcium concentration was induced by the combined drugs. The change of the calcium level presented here will open a new perspective for the discovery of synergistic mechanisms, and provide a clue for the development of drug combinations and new antifungal agents against C. albicans biofilms.
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